COMPOSITION COMPRISING AN ANDROGEN RECEPTOR BLOCKER AND AN INSULIN SENSITIZING AGENT AND USE THEREOF FOR TREATMENT OF POLYCYSTIC OVARY SYNDROME

摘要

Novels compositions comprising an endrogen receptor blocker and an insulin sensitizing agent are presented. The use of these compositions for the treatment of persons with an endocrine-metabolic disorder such as polycystic ovary syndrome is disclosed. The novel compositions are able to reduce the levels of triglycerides and male hormones. The novel compositions enables the reduction of preferentially abdominal fat resulting in a change in body composition.